Demonstrates enhanced ROS production in hypoxia-tolerant systems, suggesting a new approach for photodynamic therapy.
Photodynamic therapy (PDT) is fundamentally limited by inefficient conversion of photoexcited energy into reactive oxygen species (ROS), especially in hypoxic pathological tissues. Photogenerated radical-ion pairs (PS⁺•/PS⁻•) from photosensitizer could overcome this limitation by broadening photoredox diversity for hypoxia-tolerant ROS production. However, conventional substrate-dependent mechanism typically generates only one radical species, limiting both photoredox diversity and overall ROS production. Here we demonstrate a substrate-free mechanism via noncovalent homodimer fission for efficient generation of PS⁺•/PS⁻• pairs from water-soluble DB-Py, unlocking multipath photoredox for hypoxia-tolerant PDT. Spectroscopic studies and calculations provide experimental evidence for homodimer formation via noncovalent interactions between a photoexcited triplet-state and a ground-state molecule, followed by fission into abundant PS⁺•/PS⁻• pairs. The resulting PS⁺• oxidizes water to generate O 2 in situ, which is subsequently reduced by PS⁻• to produce •OH and O 2 ⁻•, thereby establishing a self‑oxygen‑supplying ROS generation cycle. Consequently, DB-Py achieves 4.9‑fold higher •OH and 2.7‑fold higher O 2 ⁻• compared to commercial Rose Bengal, resulting in 7.9-fold enhanced antibacterial efficacy and 2.2-fold accelerated wound epithelialization. This work establishes a substrate-free radical generation mechanism with broad implications for the development of photodynamic, photocatalytic, and photoredox systems.
No takes yet. Share an insight, caveat, or question.
Yao et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: